Delivery Order SPE2DB22D2211-SPE2DB25FRTZF

Award Date 3/26/25
Potential Completion Date 3/27/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,632,800 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $18,192.88 and is a Firm Fixed Price Delivery Order, valid through March 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,554,258 units of 8 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $4,793.97 and a completion date of March 12, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,702,158 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,654.97 and a completion date of March 27, 2025. The contract is not designated as a set-aside....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,475,528 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The award has a ceiling value of $13,318.28 and a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated....
This federal contract award, valued at $3,518.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,793,731 tablets of Ondansetron HCL 4 mg, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 4, 2024. This award is part of a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,828,704 units of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $19,733.40 and a completion date of April 8, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,076,134 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,222.47 and a period of performance ending on April 30, 2025. The contract is not set aside for any specific...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,567,320 units of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $2,154.60 and is a firm fixed-price delivery order, with a completion date of February 21, 2025. This contract is a part of a...
This federal contract award, valued at $1,134.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The award has a ceiling value of $1,325.28 and an ultimate completion date of July 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRTZF
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,705,162 units of Ondansetron HCL 4 mg Tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $3,841.04 and a period of performance through March 27, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 12:57 AM